It has been a hectic – but very enjoyable – couple of weeks representing the Society, first in Parliament in London and then at the World Congress of Pharmacology in Kyoto in Japan.
Proteolysis Targeting Chimeras (PROTACs) are heterobifunctional (two-headed) molecules that allow for highly selective targeted protein degradation (TPD). Contrary to traditional small molecule…
As pharmacologists, we know that studies using research animals have been instrumental in the discovery and development of new medicines and in our understanding of the physiological mechanisms…
Elizabeth Adeyeye, clinical pharmacology trainee at Barts Health NHS Trust, was a runner up from our 2021 annual writing competition for early career pharmacologists. For each writing competition, we…
Twice a year the British Pharmacological Society awards the Schachter Award to a postgraduate research student. The award provides up to £1,850 to support them to visit another laboratory to learn a…
The Science of a Night Out: Taking Pharmacology to the British Science Festival Dr Laura Randle, Dept of Pharmacology & Therapeutics, Liverpool. When I saw the call for activities for…
John O’Reilly, the Director General for Knowledge and Innovation at the Department for Business, Innovation & Skills (BIS) requested views and comments on the key priorities and…
The Society has opened its Fellowship to individuals who have been voting members for five years. This replaces the previous requirement, which was five years as a Full Member. This means that Early…
Professor David Webb, President of the British Pharmacological Society, comments, “The British Pharmacological Society welcomes Sir William Wakeham’s review of STEM degree provision and graduate…
